NovaBay Pharmaceuticals Inc (NBY)
0.681
-0.04
(-5.39%)
USD |
NYAM |
Nov 22, 16:00
0.673
-0.01
(-1.17%)
Pre-Market: 20:00
NovaBay Pharmaceuticals Cash from Investing (Quarterly): -0.002M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.002M |
| June 30, 2024 | -0.002M |
| March 31, 2024 | 1.068M |
| December 31, 2023 | -0.003M |
| September 30, 2023 | -0.001M |
| June 30, 2023 | -0.002M |
| March 31, 2023 | -0.013M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.08M |
| June 30, 2022 | -0.008M |
| March 31, 2022 | -0.024M |
| December 31, 2021 | -12.00M |
| September 30, 2021 | -0.017M |
| June 30, 2021 | -0.002M |
| March 31, 2021 | -0.025M |
| December 31, 2020 | -0.021M |
| September 30, 2020 | -0.005M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.005M |
| March 31, 2019 | -0.014M |
| December 31, 2018 | -0.031M |
| September 30, 2018 | -0.008M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.003M |
| March 31, 2018 | -0.002M |
| December 31, 2017 | -0.016M |
| September 30, 2017 | -0.073M |
| June 30, 2017 | -0.096M |
| March 31, 2017 | -0.059M |
| December 31, 2016 | -0.082M |
| September 30, 2016 | -0.04M |
| June 30, 2016 | -0.022M |
| March 31, 2016 | -0.016M |
| December 31, 2015 | -0.077M |
| September 30, 2015 | -0.024M |
| June 30, 2015 | -0.008M |
| March 31, 2015 | 0.023M |
| December 31, 2014 | 1.265M |
| September 30, 2014 | 2.514M |
| June 30, 2014 | 1.143M |
| March 31, 2014 | -2.324M |
| December 31, 2013 | 1.223M |
| September 30, 2013 | 0.914M |
| June 30, 2013 | -0.044M |
| March 31, 2013 | -0.686M |
| December 31, 2012 | 0.426M |
| September 30, 2012 | 0.994M |
| June 30, 2012 | -0.521M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-12.00M
Minimum
Dec 2021
1.068M
Maximum
Mar 2024
-0.5569M
Average
-0.0025M
Median
Cash from Investing (Quarterly) Benchmarks
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.713M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | 0.00 |
| Nanoviricides Inc | -0.0468M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.061M |
| Cash from Financing (Quarterly) | 2.089M |
| Free Cash Flow | -4.812M |
| Free Cash Flow Per Share (Quarterly) | -0.5561 |
| Free Cash Flow to Equity (Quarterly) | -1.418M |
| Free Cash Flow Yield | -479.8% |